Human mesenchymal stem cells
Patent Number: 6387367
Date of First Priority Issue: Friday May 29th, 1998
Date Issued: Tuesday May 14th, 2002
Assignee: Osiris Therapeutics, Inc. (Baltimore, MD)
Inventors: Davis-Sproul, Janice M. (Towson, MD); Moorman, Mark Aaron (Baltimore, MD); McNeil, Renee Marie (Baltimore, MD); Simonetti, Jr., Donald William (Forest Hill, MD); Hammill, Lora Catherine (Bel Air, MD); Craig, Stewart (Timonium, MD)
From Class: Type
Comments: No comments
This patent covers mesenchymal stem cells and provides a specific phenotype for them which includes CD45+, SH2,3,4+, and in some cases CD14+.
This patent is important for anyone operating in the area of mesenchymal stem cells since it essentially covers the use of this specific cell population.
Patents on cells have been previously upheld by the courts, as was previously illustrated for patents regarding CD34+ hematopoietic stem cell.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.